The article offers information on the increase in the costs of cancer treatment and its impact on patient well-being and discusses a presentation of physician Yousuf Zafar at the Navigation Summit. Topics discussed include the increase in the prices of the drugs such as imatinib 400, dasatinib 500 mg, and mgerlotinib 100 mg; the increasing prices of health insurance; and the impact of financial distress and risk of mortality on patient well-being.